HOXA9与核基质相关蛋白SAFB形成抑制性复合物维持急性髓系白血病
在急性髓系白血病(AML)中,HOXA9常上调并预示不良预后。研究鉴定出HOXA9与核基质附着蛋白SAFB形成染色质复合物(H9SB),该复合物招募NuRD和HP1γ抑制分化与凋亡相关基因(包括NOTCH1、CEBPδ、S100A8、CDKN1A)。扰动SAFB可模拟HOXA9敲除效应,抑制AML增殖、促进分化与凋亡并延长体内生存,该机制在其他HOXA9依赖的AML基因型中同样发挥作用。
要点
- HOXA9与SAFB形成H9SB染色质复合物,招募NuRD和HP1γ抑制分化与凋亡基因。
- 扰动SAFB可模拟HOXA9敲除,降低AML增殖、增加分化与凋亡并延长体内生存。
- 化学或遗传扰动NuRD和HP1γ催化活性同样触发分化、凋亡及肿瘤抑制基因诱导。
核心结论
- HOXA9依赖的分化阻滞是AML疾病维持的有效机制,可能通过靶向H9SB界面和/或NuRD与HP1γ活性进行治疗干预。
研究设计与样本
- 在人AML中表征内源性HOXA9的蛋白相互作用组,鉴定出HOXA9与核基质附着蛋白SAFB的染色质复合物。
- 通过SAFB扰动(模拟HOXA9敲除)在体外和体内评估对AML增殖、分化、凋亡和生存的影响。
- 整合基因组学、转录组学和蛋白质组学分析,揭示H9SB复合物与NuRD和HP1γ的关联及其靶基因。
主要发现
- SAFB扰动模拟HOXA9敲除,在体外降低AML增殖、增加分化和凋亡,并在体内延长生存。
- H9SB染色质复合物与NuRD和HP1γ关联,抑制分化与凋亡相关因子NOTCH1、CEBPδ、S100A8和CDKN1A的表达。
- 化学或遗传扰动NuRD和HP1γ相关催化活性触发分化、凋亡及上述肿瘤抑制基因的诱导。
- 该机制在其他HOXA9依赖的AML基因型中同样发挥作用。
临床怎么用
- 作者认为,靶向H9SB界面和/或NuRD与HP1γ活性可能成为治疗干预策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
HOXA9 is commonly upregulated in acute myeloid leukemia (AML), in which it confers a poor prognosis. Characterizing the protein interactome of endogenous HOXA9 in human AML, we identified a chromatin complex of HOXA9 with the nuclear matrix attachment protein SAFB. SAFB perturbation phenocopied HOXA9 knockout to decrease AML proliferation, increase differentiation and apoptosis in vitro, and prolong survival in vivo. Integrated genomic, transcriptomic, and proteomic analyses further demonstrated that the HOXA9-SAFB (H9SB)-chromatin complex associates with nucleosome remodeling and histone deacetylase (NuRD) and HP1γ to repress the expression of factors associated with differentiation and apoptosis, including NOTCH1, CEBPδ, S100A8, and CDKN1A. Chemical or genetic perturbation of NuRD and HP1γ-associated catalytic activity also triggered differentiation, apoptosis, and the induction of these tumor-suppressive genes. Importantly, this mechanism is operative in other HOXA9-dependent AML genotypes. This mechanistic insight demonstrates the active HOXA9-dependent differentiation block as a potent mechanism of disease maintenance in AML that may be amenable to therapeutic intervention by targeting the H9SB interface and/or NuRD and HP1γ activity.
引用
- Agrawal-Singh S, Bagri J, Giotopoulos G, et al. HOXA9 forms a repressive complex with nuclear matrix-associated protein SAFB to maintain acute myeloid leukemia. Blood. 2023. PMID: 36577137. doi:10.1182/blood.2022016528
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。